News Related to Optune Lua

Related coverage linked through entity extraction aliases.

FDA Approves Novocure's Electric Field Therapy for Locally Advanced Pancreatic Cancer

Feb 13, 2026

The FDA has approved Novocure's Optune Pax device for locally advanced pancreatic cancer, marking the first new treatment for this patient group in decades. A trial of 571 patients showed a two-month improvement in overall survival when combined with chemotherapy.

FDA Approves Optune Pax for Locally Advanced Pancreatic Cancer, First New Treatment in Decades

Feb 13, 2026

The FDA approved Novocure's Optune Pax device for locally advanced pancreatic cancer treatment alongside chemotherapy, marking the first new treatment option in this indication since 1996. Phase III trial data showed statistically significant survival improvement.